Article ID Journal Published Year Pages File Type
6006481 Clinical Neurology and Neurosurgery 2014 4 Pages PDF
Abstract
Fingolimod is safe and effective in reducing clinical and radiological disease activity in relapsing remitting MS patients. Our results are comparable to reported results of phase III studies.
Keywords
Related Topics
Life Sciences Neuroscience Neurology
Preview
Use of fingolimod in patients with relapsing remitting multiple sclerosis in Kuwait
Authors
, , , ,